Lensar (LNSR) Revenue (QoQ) (2019 - 2026)
Lensar (LNSR) Revenue (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.22 Bn | 6.27 Bn |
| 2 | Stryker | 128.20 Bn | 125.32 Bn | 3.81 Bn |
| 3 | Medtronic | 107.69 Bn | 98.47 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.05 Bn | 66.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.52 Bn | 43.85 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.46 Bn | 26.17 Bn | 1.98 Bn |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.73 Bn | 26.15 Bn | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn |
| 10 | Lensar | 66.89 Mn | 55.79 Mn | 6.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.23% |
| Dec 31, 2025 | -27.52% |
| Sep 30, 2025 | 3.79% |
| Jun 30, 2025 | -13.20% |
| Mar 31, 2025 | 53.92% |
| Dec 31, 2024 | -22.14% |
| Sep 30, 2024 | 10.59% |
| Jun 30, 2024 | 3,584.14% |
| Mar 31, 2024 | -97.24% |
| Dec 31, 2023 | 26.96% |
| Sep 30, 2023 | -19.86% |
| Jun 30, 2023 | 25.07% |
| Mar 31, 2023 | -4.08% |
| Dec 31, 2022 | 11.04% |
| Sep 30, 2022 | 16.99% |
| Jun 30, 2022 | -29.09% |
| Mar 31, 2022 | -16.77% |
| Dec 31, 2021 | 60.61% |
| Sep 30, 2021 | 3.02% |
| Jun 30, 2021 | 14.33% |